We would love to hear your thoughts about our site and services, please take our survey here.
I'm actually still holding, its only be a small holding but it still gives me the right to be critical and stop others being sucked in. I went long at 4.50p a few months ago, my punt was based almost solely on Kight holdings and nothing to do with the underlying product. You would have to have some kind of end game to invest so much into this highly risky penny share and this is what I'm gambling on. I hadn't factored in that it could have been a reckless investment and if so more the fool me for following him.
One thing is becoming more apparent by the day, the money is running out and there will be another cash call in around a year.
11 year old video, if it had any substance it would have been fully exploited by now.
Question is how much good money after bad do you throw at this, and surely if it was that promising the bods would be fully invested.
The cold reality of the current share price and his paper loss says differently
My sympathy goes out to Kight, how he got suckered into his massive holding is beyond me, he would have been so much better sticking with a managed fund.
These time lines keep getting extended further out
"Our partner Juvenescence is progressing well towards market launch within the next two years"
Same statement they made when they first announced it 2 1/2 years ago.
All announcements seem to be converging to when the cash runs out and just in time for the next fund raise.
The massive red flag for me is that the bods aren't buying in.
Can't be much longer now, I think news, good or bad is just days away. Odds are it will be unsuccessful but you never know.
You are all absolutely right, I have a zero medical background and am solely basing my thoughts on gut feelings, I just can't fathom that a combination of drugs could relieve autism, we are definitely seeping down the snake oil route with this one.
Still I'm holding so if I'm wrong I'll be more than delighted for the family member as well as from a financial perspective.
I base my opinion on a very close family member being on the autistic spectrum. If you think SFX is a possible cure you're all more delusional than I thought and completely devoid of any rationale thought. You'll all realise that I was right once the results are announced. Don't get me wrong it could well have a possible cure for other issues but never in a million years would it have any benefit for anyone on the autism spectrum.
I'm almost certain the Stalica SA cooperation will result in a total failure. Once someone has autism there is absolutely no way a drug could reverse the disorder. The company needs to persue more realistic targets. Enlarged prostate is a very common thing in older gentleman and causes a lot of discomfort, eating lots of broccoli has been shown to reduce the size so why not focus on that area. Admittedly if a company comes along and offers you money your not going to turn it down but this is doing nothing for the long term share value as the negative results causes another sell off. I think the bods are fully aware of this hence their hesitancy in buying in. I think SFX could well have a medical benefit, the bods need to pull their finger out and persue realistic avenues.
Here's me hoping again but what are the odds of a Friday rally following some positive news ??
I could delude myself and say the darkest hour is just before dawn but I don't really believe it.
What is a certainty is that the bods live in constant daylight. I'm just waiting for them to roll out that promised breast cancer cure the company has been going on about for over 10 years and never properly progressed any further. Clearly a joker for the back pocket for the next time they tap investors to further fund their life styles and pensions.
Score - you're in good company, I would say almost 100% of holders are under water by various degrees. Only winners are the Bods who keep milking the company's coffers, promise so much, but deliver nothing when it comes to share price appreciation all the while keeping their personal funds well away from this company. Good luck with your next punt.
Well last weeks move seem again to have been orchestra by the MM to suck in more buyers. Maybe we should organise ourselves and corner the market, with over 50% of shares in private hands wouldn't take much to give the shorters a bloody nose, who knows if the bods might get a kicking.
CJ39 - I've been a sceptic of this share probably as long as Radar. The main negatives for me is that the BODs have no skin in the game, and I can't shake the feeling it's one elaborate gravey train for their personal gain at the detriment of the shareholders. I'm also prepared to take a punt, if Kight is willing to buy a 12% stake in the company, and 50% of the free float is held in private hands this could well have some potential. Sadly your odds of success are way to optimistic in my opinion, the market average for success with these types of companies is probably nearer to 100 to 1. I also have a holding but mine is more reflective of my odds of success. I'm hoping Evgen does succeed and that we are all winners to various degrees, rather than all being losers and Radar constantly reminding us of it.
Hopefully someone is in the know and this could be the start of a substantial leg up. Alternatively the MM could be moving this up to entice some unsuspecting punters to part with more of their money and this could be another false dawn.
Personally I'm in the later camp, but will be more than happy if proved wrong.
Obviously with all the turmoil with the Americans it is a little hard to call the bottom but with the likelihood of a further 0.25 % increase coming next week their free money in the form of higher returns on surplus cash can only increase. NatWest were basing rates a 4.00 % the reality will be closer to 4.75 or even 5.00%. This will result in far higher profits and inturn higher dividend payouts. My view is if you can keep your nerve you should be handsomely rewarded, but I could well be wrong so please do your own research.
I really hope you're right niss, but my gut tells me it's likely to be the usual RNS, "Surprised and disappointed with the results". Hopefully they announce the commencement or royalty payments from Juvenescence to soften the blow.
I do find this also a little concerning, when they first announced this back in September 2020, they stated that the payments would start around the 4th quarter of 2022. The RNS of the time seems to have been amended so as to not include this.
I do feel we are all being duped into keeping the gravy train chugging along for the bods, still Kight seems content with his massive holding so I shouldn't really be moaning with my meagre holding. Rant over, fingers crossed for positive news.
Rishab - No disrespect but if you're having to ask these questions and are not able to find the answers under your own volition you clearly are not doing any of your own research and should possibly stick to managed funds. You get a lot of strong views on these sites mainly based on peoples positions, if you just go with what you read you could well come a cropper.
Uktonto - Agree, they sold off last time when they announced lower margin. Some state the 11bn outflow as the reason, I personally feel that both Barclays and Lloyds would have been hammered which is not the case. Still a massive gap to around £2.72 needs filling, as well as 2.89 and £3.01. they'll be up sooner rather than later but I am surprised with the sell off
Sell off due the First Republic sell off, banks are an integral part of the economy and never in a million years would the let this spread. We as tax payers will always end up bailing out these unscrupulous players. Nothing will change while the only repercussions for failure is a slapped wrist and they get to keep all their personal wealth and pension entitlements.
Back to NatWest, headline grabbing first quarter profits due to be announced on Friday.